-
公开(公告)号:WO2022261344A1
公开(公告)日:2022-12-15
申请号:PCT/US2022/032862
申请日:2022-06-09
IPC分类号: A61K31/195 , A61K9/00 , A61K31/00
摘要: The present invention features methods and compositions for the subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
-
公开(公告)号:WO2022261344A8
公开(公告)日:2022-12-15
申请号:PCT/US2022/032862
申请日:2022-06-09
IPC分类号: A61K31/195 , A61K9/00 , A61K31/00 , A61K31/196 , A61K47/10 , A61K47/183 , A61K47/26 , A61K9/0019
摘要: The present invention features methods and compositions for the subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
-
公开(公告)号:WO2021113775A1
公开(公告)日:2021-06-10
申请号:PCT/US2020/063491
申请日:2020-12-04
IPC分类号: A61K31/431 , A61K31/496 , A61K31/546 , A61K31/196 , A61K47/38 , A61K9/0019 , A61K9/0043 , A61K9/006 , A61K9/08 , A61K9/107 , A61P7/10 , A61P9/04
摘要: The present invention features methods and compositions for the intranasal, sublingual, and subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
-
-